SlideShare a Scribd company logo
REAL-TIME
REAL-WORLD
*Protocol Finalization to Last Patient In Phase I-IV.
>175k
unique investigators
>15k
protocols
EXCEEDING RECRUITMENT GOALS FOR A
GLOBAL MULTI-STUDY REGISTRATION PROGRAM
PILOTING A VIRTUAL REAL WORLD
EVIDENCE STUDY
CLIENT CHALLENGE
CLIENT CHALLENGE
REAL-WORLD IMPACT
REAL-WORLD IMPACT
Result: Achieved “first patient in” requirement ahead of schedule for all studies in the program.
Beat historical industry performance across a number of key metrics:
18% fewer weeks from final protocol to FPI | 75% more high-performing sites
31% more patients/site/month | 41% fewer non-performing sites
Result: Conducted two successful pilot studies recruiting 315 patients across 65 Patient Service Centers.
The pharma company is planning to scale up 10x from the pilot to a full national model.
Randomize 2,700
patients within a very
narrow timeframe for
a suite of registration
studies
Develop a less costly,
“site-less” approach
to conduct a study
collecting survey and
laboratory data
Study needed to be
national in scope
while reducing the
patient travel burden
Leveraged Xcellerate® historical
investigator database to
identify and secure highest
performing investigators in
indication
Get all sites across
the globe up and
running as quickly
as possible
Based on extensive feasibility outreach
and site capacity assessment,
efficiencies were identified that
allowed effective overlapping of
sites across the program resulting in
accelerated site start-up and reduced
clinical costs
Developed a cross-enterprise
virtual study model leveraging
the Covance patient support call
center, local LabCorp Patient
Service Centers and Covance
Central Labs to screen participants,
collect lab specimens and analyze
lab results, respectively
•	Online screening, e-consent
and enrollment
•	Call center acting as virtual
site coordinators
•	Fully integrated project
oversight and data management
LabCorp
Patient Service Centers
in the pilot
65
Million Patients
>150
million patients
>30
billion test results
RESCUED PATIENT ENROLLMENT FOR A
STUDY OF A RARE MUTATION
PROTOCOL DESIGN TO MAXIMIZE
PATIENT ENROLLMENT OPPORTUNITY
CLIENT CHALLENGE
CLIENT CHALLENGE REAL-WORLD IMPACT
REAL-WORLD IMPACT
Result: With 274 sites across 28 countries, patient enrollment is on now on track for the initial
milestone and has regained its advantage in the recruitment competitive landscape.
Result: The eligible patient population increased by +50% without
compromising the objectives of the trial.
Analyzed LabCorp de-identified
clinical laboratory data to discern
whether small protocol changes
could accelerate recruitment
Leveraged LabCorp de-identified
clinical laboratory data with
health information on patients
with the rare mutation
Increased recruitment activities
in the US leveraging the
LabCorp sales force to reach
out to physicians to gauge
interest as investigators and
to recruit AML patients
Data helped to identify that
making minor changes to the
eGFR cutoff would increase
the patient pool size therefore
reducing recruitment timelines
Study to test if a drug
reduced progression of
kidney disease in patients
with Type II diabetes
Difficulty identifying
available sites as
landscape changed
rapidly driving
increased
competition
Pharma’s preferred
sites were
unavailable
Study was looking for a
small subset of patients
which represented
<7% of patients
Seeking patients with AML
and a rare genetic mutation
<15% of AML patients
>
*Average time savings based on an analysis of trials processed through Covance Central Labs with Protocol
Finalization date after 1/1/2009 for the specific clinical indications. Past performance is not a guarantee of
future results, and a variety of factors other than CRO performance can impact timing of clinical studies.
Covance Inc. is the global drug development business
of Laboratory Corporation of America Holdings
(LabCorp). COVANCE is a registered trademark and
marketing name used by Covance Inc. and its
subsidiaries around the world.
The Americas +1.888.COVANCE (+1.888.268.2623)
+1.609.452.4440 or +1.910.338.4760
Europe/Africa +00.800.2682.2682
+44.1423.500888 or +44.1753.512000
Asia Pacific +800.6568.3000 +65.6.5686588
© Copyright 2018 Covance Inc. BROCVD018-0618
REAL-TIME DATA. REAL-WORLD IMPACT.
Talk to a representative to find out how Covance can impact your studies.
LEARN MORE AT COVANCE.COM/REALIMPACT
FOR DATA-DRIVEN RESULTS, IQ IS NOT ENOUGH.
Up to 60% of clinical development time and 40% of cost are spent on patient
recruitment. Data can help, but simply accessing more data only muddies your
decision making. With Covance, you get the right analysis on the right data to
empower your studies. Recruit eligible patients that fit your protocol faster, identify
and secure proven and/or new sites, forecast and measure progress more
efficiently. With Covance’s proprietary data, your program hits its mark.
PROTOCOL FINALIZATION TO LAST PATIENT IN
Number of Weeks*

More Related Content

What's hot

The Use of EDC in Canadian Clinical Trials
The Use of EDC in Canadian Clinical TrialsThe Use of EDC in Canadian Clinical Trials
The Use of EDC in Canadian Clinical Trials
Khaled El Emam
 
On the ground experiences & challenges of a connected diagnostics GxAlert in ...
On the ground experiences & challenges of a connected diagnostics GxAlert in ...On the ground experiences & challenges of a connected diagnostics GxAlert in ...
On the ground experiences & challenges of a connected diagnostics GxAlert in ...
SystemOne
 
Roadmap Molecular Diagnostics
Roadmap Molecular DiagnosticsRoadmap Molecular Diagnostics
Roadmap Molecular Diagnostics
EuroBioForum
 
Roche Diagnostics
Roche DiagnosticsRoche Diagnostics
Roche Diagnostics
love4mihir
 
05 zittartz presentation_ph_v_day_2014
05 zittartz presentation_ph_v_day_201405 zittartz presentation_ph_v_day_2014
05 zittartz presentation_ph_v_day_2014
pharmasol
 
Annual Results and Impact Evaluation Workshop for RBF - Day One - Using OP Da...
Annual Results and Impact Evaluation Workshop for RBF - Day One - Using OP Da...Annual Results and Impact Evaluation Workshop for RBF - Day One - Using OP Da...
Annual Results and Impact Evaluation Workshop for RBF - Day One - Using OP Da...
RBFHealth
 
Pilot Implementation of Point-Of-Care, CD4 Counting in Mozambique’s National ...
Pilot Implementation of Point-Of-Care, CD4 Counting in Mozambique’s National ...Pilot Implementation of Point-Of-Care, CD4 Counting in Mozambique’s National ...
Pilot Implementation of Point-Of-Care, CD4 Counting in Mozambique’s National ...
UNITAID
 
Improving Processes for Temperature Traceability from Packaging to Patient
Improving Processes for Temperature Traceability from Packaging to PatientImproving Processes for Temperature Traceability from Packaging to Patient
Improving Processes for Temperature Traceability from Packaging to Patient
PAREXEL International
 
Nscbl slide
Nscbl slideNscbl slide
Nscbl slide
Mmedsc Hahm
 
Carevive featured in Advisory Board Company Oncology Rountable
Carevive featured in Advisory Board Company Oncology RountableCarevive featured in Advisory Board Company Oncology Rountable
Carevive featured in Advisory Board Company Oncology Rountable
Carevive
 
resume
resumeresume
National annual report
National annual reportNational annual report
National annual report
CACTUS_JP
 
You're Hot Then You're Cold - Temperature Management & RTSM Integration
You're Hot Then You're Cold - Temperature Management & RTSM IntegrationYou're Hot Then You're Cold - Temperature Management & RTSM Integration
You're Hot Then You're Cold - Temperature Management & RTSM Integration
PAREXEL International
 
TGA presentation: Update on recent activities
TGA presentation: Update on recent activitiesTGA presentation: Update on recent activities
TGA presentation: Update on recent activities
TGA Australia
 
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Covance
 
Introduction to DRIVE - Cedric Mahe
Introduction to DRIVE - Cedric MaheIntroduction to DRIVE - Cedric Mahe
Introduction to DRIVE - Cedric Mahe
DRIVE research
 
IQ consortium survey pkpd modeling in pharma
IQ consortium survey   pkpd modeling in pharmaIQ consortium survey   pkpd modeling in pharma
IQ consortium survey pkpd modeling in pharma
Certara
 
David cocker feasibility_and_web_mining
David cocker feasibility_and_web_miningDavid cocker feasibility_and_web_mining
David cocker feasibility_and_web_mining
David Cocker
 
Using risk-based approaches across the product lifecycle to simplify, standar...
Using risk-based approaches across the product lifecycle to simplify, standar...Using risk-based approaches across the product lifecycle to simplify, standar...
Using risk-based approaches across the product lifecycle to simplify, standar...
MyMeds&Me
 
How PerkinElmer became world's market leader?, Marika Kase
How PerkinElmer became world's market leader?, Marika KaseHow PerkinElmer became world's market leader?, Marika Kase
How PerkinElmer became world's market leader?, Marika Kase
Business Turku
 

What's hot (20)

The Use of EDC in Canadian Clinical Trials
The Use of EDC in Canadian Clinical TrialsThe Use of EDC in Canadian Clinical Trials
The Use of EDC in Canadian Clinical Trials
 
On the ground experiences & challenges of a connected diagnostics GxAlert in ...
On the ground experiences & challenges of a connected diagnostics GxAlert in ...On the ground experiences & challenges of a connected diagnostics GxAlert in ...
On the ground experiences & challenges of a connected diagnostics GxAlert in ...
 
Roadmap Molecular Diagnostics
Roadmap Molecular DiagnosticsRoadmap Molecular Diagnostics
Roadmap Molecular Diagnostics
 
Roche Diagnostics
Roche DiagnosticsRoche Diagnostics
Roche Diagnostics
 
05 zittartz presentation_ph_v_day_2014
05 zittartz presentation_ph_v_day_201405 zittartz presentation_ph_v_day_2014
05 zittartz presentation_ph_v_day_2014
 
Annual Results and Impact Evaluation Workshop for RBF - Day One - Using OP Da...
Annual Results and Impact Evaluation Workshop for RBF - Day One - Using OP Da...Annual Results and Impact Evaluation Workshop for RBF - Day One - Using OP Da...
Annual Results and Impact Evaluation Workshop for RBF - Day One - Using OP Da...
 
Pilot Implementation of Point-Of-Care, CD4 Counting in Mozambique’s National ...
Pilot Implementation of Point-Of-Care, CD4 Counting in Mozambique’s National ...Pilot Implementation of Point-Of-Care, CD4 Counting in Mozambique’s National ...
Pilot Implementation of Point-Of-Care, CD4 Counting in Mozambique’s National ...
 
Improving Processes for Temperature Traceability from Packaging to Patient
Improving Processes for Temperature Traceability from Packaging to PatientImproving Processes for Temperature Traceability from Packaging to Patient
Improving Processes for Temperature Traceability from Packaging to Patient
 
Nscbl slide
Nscbl slideNscbl slide
Nscbl slide
 
Carevive featured in Advisory Board Company Oncology Rountable
Carevive featured in Advisory Board Company Oncology RountableCarevive featured in Advisory Board Company Oncology Rountable
Carevive featured in Advisory Board Company Oncology Rountable
 
resume
resumeresume
resume
 
National annual report
National annual reportNational annual report
National annual report
 
You're Hot Then You're Cold - Temperature Management & RTSM Integration
You're Hot Then You're Cold - Temperature Management & RTSM IntegrationYou're Hot Then You're Cold - Temperature Management & RTSM Integration
You're Hot Then You're Cold - Temperature Management & RTSM Integration
 
TGA presentation: Update on recent activities
TGA presentation: Update on recent activitiesTGA presentation: Update on recent activities
TGA presentation: Update on recent activities
 
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
 
Introduction to DRIVE - Cedric Mahe
Introduction to DRIVE - Cedric MaheIntroduction to DRIVE - Cedric Mahe
Introduction to DRIVE - Cedric Mahe
 
IQ consortium survey pkpd modeling in pharma
IQ consortium survey   pkpd modeling in pharmaIQ consortium survey   pkpd modeling in pharma
IQ consortium survey pkpd modeling in pharma
 
David cocker feasibility_and_web_mining
David cocker feasibility_and_web_miningDavid cocker feasibility_and_web_mining
David cocker feasibility_and_web_mining
 
Using risk-based approaches across the product lifecycle to simplify, standar...
Using risk-based approaches across the product lifecycle to simplify, standar...Using risk-based approaches across the product lifecycle to simplify, standar...
Using risk-based approaches across the product lifecycle to simplify, standar...
 
How PerkinElmer became world's market leader?, Marika Kase
How PerkinElmer became world's market leader?, Marika KaseHow PerkinElmer became world's market leader?, Marika Kase
How PerkinElmer became world's market leader?, Marika Kase
 

Similar to Real-Time Data. Real-World Impact Brochure

Real-Time Data. Real-World Impact.
Real-Time Data. Real-World Impact.Real-Time Data. Real-World Impact.
Real-Time Data. Real-World Impact.
Covance
 
A Smart Alternative For Specimen Collection - Patient Service Center Visits
A Smart Alternative For Specimen Collection - Patient Service Center Visits A Smart Alternative For Specimen Collection - Patient Service Center Visits
A Smart Alternative For Specimen Collection - Patient Service Center Visits
Covance
 
Sanguine sales deck_2015_jg_updated
Sanguine sales deck_2015_jg_updatedSanguine sales deck_2015_jg_updated
Sanguine sales deck_2015_jg_updated
CarlynSanguine
 
Real-Time Data. Real-World Impact. Infographic
Real-Time Data. Real-World Impact. InfographicReal-Time Data. Real-World Impact. Infographic
Real-Time Data. Real-World Impact. Infographic
Covance
 
Roundup of This Year's AACC Meeting in Atlanta
Roundup of This Year's AACC Meeting in AtlantaRoundup of This Year's AACC Meeting in Atlanta
Roundup of This Year's AACC Meeting in Atlanta
Bruce Carlson
 
Evoulution Summit_November_2015_Sundgren
Evoulution Summit_November_2015_SundgrenEvoulution Summit_November_2015_Sundgren
Evoulution Summit_November_2015_Sundgren
Mats Sundgren
 
MCC WEBINAR | KRIs - The Vital Few
MCC WEBINAR | KRIs - The Vital FewMCC WEBINAR | KRIs - The Vital Few
MCC WEBINAR | KRIs - The Vital Few
Cyntegrity | Data Science for Clinical Trials
 
MicroBioDx - Turnkey In Office PCR Labs with UTI, RPP and More
MicroBioDx - Turnkey In Office PCR Labs with UTI, RPP and MoreMicroBioDx - Turnkey In Office PCR Labs with UTI, RPP and More
MicroBioDx - Turnkey In Office PCR Labs with UTI, RPP and More
MaxiMedRx
 
2014 Berlin_ Operational Excellence in Clinical Trails
2014 Berlin_ Operational Excellence in Clinical Trails2014 Berlin_ Operational Excellence in Clinical Trails
2014 Berlin_ Operational Excellence in Clinical Trails
Karen Radley
 
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...
GenesisCareUK
 
Point Of Care Testing
Point Of Care TestingPoint Of Care Testing
Point Of Care Testing
LAB IDEA
 
Racing for results: lessons learnt in improving the efficiency of HIV VL and ...
Racing for results: lessons learnt in improving the efficiency of HIV VL and ...Racing for results: lessons learnt in improving the efficiency of HIV VL and ...
Racing for results: lessons learnt in improving the efficiency of HIV VL and ...
SystemOne
 
Diagnostics Market Disruption HIDA final
Diagnostics Market Disruption HIDA finalDiagnostics Market Disruption HIDA final
Diagnostics Market Disruption HIDA final
Hidee Cyd
 
Post AMM
Post AMMPost AMM
Post AMM
AdScientiam
 
OR Efficiency Solution from Core Mobile
OR Efficiency Solution from Core MobileOR Efficiency Solution from Core Mobile
OR Efficiency Solution from Core Mobile
Bruce Bain
 
white-paper-innovation-clinical-trials
white-paper-innovation-clinical-trialswhite-paper-innovation-clinical-trials
white-paper-innovation-clinical-trials
Ulrich Neumann, FRSA
 
Point of Care Testing for Enhancing Patient Centered Planned Care Delivery
Point of Care Testing for Enhancing Patient Centered Planned Care DeliveryPoint of Care Testing for Enhancing Patient Centered Planned Care Delivery
Point of Care Testing for Enhancing Patient Centered Planned Care Delivery
PAFP
 
Qps Presentation
Qps PresentationQps Presentation
Qps Presentation
brendonbourg
 
Accelerating the translation of medical research - 27 June
Accelerating the translation of medical research - 27 JuneAccelerating the translation of medical research - 27 June
Accelerating the translation of medical research - 27 June
Innovation Agency
 
DEC 3 2015 Mats Sundgren
DEC 3 2015 Mats SundgrenDEC 3 2015 Mats Sundgren
DEC 3 2015 Mats Sundgren
GBX Events
 

Similar to Real-Time Data. Real-World Impact Brochure (20)

Real-Time Data. Real-World Impact.
Real-Time Data. Real-World Impact.Real-Time Data. Real-World Impact.
Real-Time Data. Real-World Impact.
 
A Smart Alternative For Specimen Collection - Patient Service Center Visits
A Smart Alternative For Specimen Collection - Patient Service Center Visits A Smart Alternative For Specimen Collection - Patient Service Center Visits
A Smart Alternative For Specimen Collection - Patient Service Center Visits
 
Sanguine sales deck_2015_jg_updated
Sanguine sales deck_2015_jg_updatedSanguine sales deck_2015_jg_updated
Sanguine sales deck_2015_jg_updated
 
Real-Time Data. Real-World Impact. Infographic
Real-Time Data. Real-World Impact. InfographicReal-Time Data. Real-World Impact. Infographic
Real-Time Data. Real-World Impact. Infographic
 
Roundup of This Year's AACC Meeting in Atlanta
Roundup of This Year's AACC Meeting in AtlantaRoundup of This Year's AACC Meeting in Atlanta
Roundup of This Year's AACC Meeting in Atlanta
 
Evoulution Summit_November_2015_Sundgren
Evoulution Summit_November_2015_SundgrenEvoulution Summit_November_2015_Sundgren
Evoulution Summit_November_2015_Sundgren
 
MCC WEBINAR | KRIs - The Vital Few
MCC WEBINAR | KRIs - The Vital FewMCC WEBINAR | KRIs - The Vital Few
MCC WEBINAR | KRIs - The Vital Few
 
MicroBioDx - Turnkey In Office PCR Labs with UTI, RPP and More
MicroBioDx - Turnkey In Office PCR Labs with UTI, RPP and MoreMicroBioDx - Turnkey In Office PCR Labs with UTI, RPP and More
MicroBioDx - Turnkey In Office PCR Labs with UTI, RPP and More
 
2014 Berlin_ Operational Excellence in Clinical Trails
2014 Berlin_ Operational Excellence in Clinical Trails2014 Berlin_ Operational Excellence in Clinical Trails
2014 Berlin_ Operational Excellence in Clinical Trails
 
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...
 
Point Of Care Testing
Point Of Care TestingPoint Of Care Testing
Point Of Care Testing
 
Racing for results: lessons learnt in improving the efficiency of HIV VL and ...
Racing for results: lessons learnt in improving the efficiency of HIV VL and ...Racing for results: lessons learnt in improving the efficiency of HIV VL and ...
Racing for results: lessons learnt in improving the efficiency of HIV VL and ...
 
Diagnostics Market Disruption HIDA final
Diagnostics Market Disruption HIDA finalDiagnostics Market Disruption HIDA final
Diagnostics Market Disruption HIDA final
 
Post AMM
Post AMMPost AMM
Post AMM
 
OR Efficiency Solution from Core Mobile
OR Efficiency Solution from Core MobileOR Efficiency Solution from Core Mobile
OR Efficiency Solution from Core Mobile
 
white-paper-innovation-clinical-trials
white-paper-innovation-clinical-trialswhite-paper-innovation-clinical-trials
white-paper-innovation-clinical-trials
 
Point of Care Testing for Enhancing Patient Centered Planned Care Delivery
Point of Care Testing for Enhancing Patient Centered Planned Care DeliveryPoint of Care Testing for Enhancing Patient Centered Planned Care Delivery
Point of Care Testing for Enhancing Patient Centered Planned Care Delivery
 
Qps Presentation
Qps PresentationQps Presentation
Qps Presentation
 
Accelerating the translation of medical research - 27 June
Accelerating the translation of medical research - 27 JuneAccelerating the translation of medical research - 27 June
Accelerating the translation of medical research - 27 June
 
DEC 3 2015 Mats Sundgren
DEC 3 2015 Mats SundgrenDEC 3 2015 Mats Sundgren
DEC 3 2015 Mats Sundgren
 

More from Covance

Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Covance
 
Genomics Solutions - Single Target to Whole Genome Analysis
Genomics Solutions - Single Target to Whole Genome AnalysisGenomics Solutions - Single Target to Whole Genome Analysis
Genomics Solutions - Single Target to Whole Genome Analysis
Covance
 
Pharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for BiosimilarsPharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for Biosimilars
Covance
 
Cell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval SolutionsCell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval Solutions
Covance
 
Cell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise Solutions
Covance
 
Cell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development SolutionsCell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development Solutions
Covance
 
Inhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory TreatmentsInhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory Treatments
Covance
 
Covance Laboratory FSPx Solutions
Covance Laboratory FSPx SolutionsCovance Laboratory FSPx Solutions
Covance Laboratory FSPx Solutions
Covance
 
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
Covance
 
Environmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical DrugsEnvironmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical Drugs
Covance
 
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Covance
 
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric ProgramPutting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
Covance
 
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty MarketTop 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Covance
 
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Covance
 
Covance Phase IV Solutions Brochure
Covance Phase IV Solutions BrochureCovance Phase IV Solutions Brochure
Covance Phase IV Solutions Brochure
Covance
 
Optimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access ExperienceOptimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access Experience
Covance
 
Patient Safety Cloud Solution Brochure
Patient Safety Cloud Solution BrochurePatient Safety Cloud Solution Brochure
Patient Safety Cloud Solution Brochure
Covance
 
Plant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant CultivationPlant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant Cultivation
Covance
 
Biocide Authorization Timeline
Biocide Authorization TimelineBiocide Authorization Timeline
Biocide Authorization Timeline
Covance
 
K-REACH - How to Prepare for the K-REACH Legislation
K-REACH - How to Prepare for the K-REACH LegislationK-REACH - How to Prepare for the K-REACH Legislation
K-REACH - How to Prepare for the K-REACH Legislation
Covance
 

More from Covance (20)

Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
 
Genomics Solutions - Single Target to Whole Genome Analysis
Genomics Solutions - Single Target to Whole Genome AnalysisGenomics Solutions - Single Target to Whole Genome Analysis
Genomics Solutions - Single Target to Whole Genome Analysis
 
Pharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for BiosimilarsPharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for Biosimilars
 
Cell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval SolutionsCell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval Solutions
 
Cell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise Solutions
 
Cell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development SolutionsCell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development Solutions
 
Inhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory TreatmentsInhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory Treatments
 
Covance Laboratory FSPx Solutions
Covance Laboratory FSPx SolutionsCovance Laboratory FSPx Solutions
Covance Laboratory FSPx Solutions
 
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
 
Environmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical DrugsEnvironmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical Drugs
 
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
 
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric ProgramPutting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
 
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty MarketTop 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
 
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
 
Covance Phase IV Solutions Brochure
Covance Phase IV Solutions BrochureCovance Phase IV Solutions Brochure
Covance Phase IV Solutions Brochure
 
Optimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access ExperienceOptimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access Experience
 
Patient Safety Cloud Solution Brochure
Patient Safety Cloud Solution BrochurePatient Safety Cloud Solution Brochure
Patient Safety Cloud Solution Brochure
 
Plant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant CultivationPlant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant Cultivation
 
Biocide Authorization Timeline
Biocide Authorization TimelineBiocide Authorization Timeline
Biocide Authorization Timeline
 
K-REACH - How to Prepare for the K-REACH Legislation
K-REACH - How to Prepare for the K-REACH LegislationK-REACH - How to Prepare for the K-REACH Legislation
K-REACH - How to Prepare for the K-REACH Legislation
 

Recently uploaded

The Importance of Public Relations for New Graduates.pdf
The Importance of Public Relations for New Graduates.pdfThe Importance of Public Relations for New Graduates.pdf
The Importance of Public Relations for New Graduates.pdf
Posh Concepts
 
Restaurant Chiraz Sindbad Hotel Hammamet
Restaurant Chiraz Sindbad Hotel HammametRestaurant Chiraz Sindbad Hotel Hammamet
Restaurant Chiraz Sindbad Hotel Hammamet
rihabkorbi24
 
WAM Corporate Presentation July 2024.pdf
WAM Corporate Presentation July 2024.pdfWAM Corporate Presentation July 2024.pdf
WAM Corporate Presentation July 2024.pdf
Western Alaska Minerals Corp.
 
Floating Pontoon | Premier marine solution
Floating Pontoon | Premier marine solutionFloating Pontoon | Premier marine solution
Floating Pontoon | Premier marine solution
PMSME
 
upGrad_Case_Study_by_Himanshu_Singh.pptx
upGrad_Case_Study_by_Himanshu_Singh.pptxupGrad_Case_Study_by_Himanshu_Singh.pptx
upGrad_Case_Study_by_Himanshu_Singh.pptx
himanshubclubofgsv
 
What's your strategy? Getting tactical about being strategic.
What's your strategy? Getting tactical about being strategic.What's your strategy? Getting tactical about being strategic.
What's your strategy? Getting tactical about being strategic.
Doug Hall
 
Movers near me in Dubai , Best Packers and Movers In Dubai
Movers near me in Dubai , Best Packers and Movers In DubaiMovers near me in Dubai , Best Packers and Movers In Dubai
Movers near me in Dubai , Best Packers and Movers In Dubai
imranmalik114455
 
Virtual Production Tool Set and Technologies Redefining Cinema.pdf
Virtual Production Tool Set and Technologies Redefining Cinema.pdfVirtual Production Tool Set and Technologies Redefining Cinema.pdf
Virtual Production Tool Set and Technologies Redefining Cinema.pdf
virtualproduction38
 
Gym business MODEL .pdf .
Gym business MODEL .pdf                 .Gym business MODEL .pdf                 .
Gym business MODEL .pdf .
Divyanshu56740
 
Busty Girls Call Navi Mumbai 🎈🔥9920725232 🔥💋🎈 Provide Best And Top Girl Servi...
Busty Girls Call Navi Mumbai 🎈🔥9920725232 🔥💋🎈 Provide Best And Top Girl Servi...Busty Girls Call Navi Mumbai 🎈🔥9920725232 🔥💋🎈 Provide Best And Top Girl Servi...
Busty Girls Call Navi Mumbai 🎈🔥9920725232 🔥💋🎈 Provide Best And Top Girl Servi...
bellared2
 
ハワイ大学留学プログラム最終プレゼン「ハワイ大学マノア校におけるシェアリングモビリティの提案」
ハワイ大学留学プログラム最終プレゼン「ハワイ大学マノア校におけるシェアリングモビリティの提案」ハワイ大学留学プログラム最終プレゼン「ハワイ大学マノア校におけるシェアリングモビリティの提案」
ハワイ大学留学プログラム最終プレゼン「ハワイ大学マノア校におけるシェアリングモビリティの提案」
Katsuya Shiratori
 
Honoring and Understanding the Significance of Guru Purnima
Honoring and Understanding the Significance of Guru PurnimaHonoring and Understanding the Significance of Guru Purnima
Honoring and Understanding the Significance of Guru Purnima
Exotic India
 
FURI88 : GAME SLOT PGSOFT PALING GACOR MUDAH MENANG HANYA DISINI
FURI88 : GAME SLOT PGSOFT PALING GACOR MUDAH MENANG HANYA DISINIFURI88 : GAME SLOT PGSOFT PALING GACOR MUDAH MENANG HANYA DISINI
FURI88 : GAME SLOT PGSOFT PALING GACOR MUDAH MENANG HANYA DISINI
FURI88 ONLINE
 
High Girls Call Nashik 000XX00000 Provide Best And Top Girl Service And No1 i...
High Girls Call Nashik 000XX00000 Provide Best And Top Girl Service And No1 i...High Girls Call Nashik 000XX00000 Provide Best And Top Girl Service And No1 i...
High Girls Call Nashik 000XX00000 Provide Best And Top Girl Service And No1 i...
susmagarg02
 
A Playbook for Solo & Siloed Data Science Practitioners
A Playbook for Solo & Siloed Data Science PractitionersA Playbook for Solo & Siloed Data Science Practitioners
A Playbook for Solo & Siloed Data Science Practitioners
Tim Wilson
 
Chief Compliance Officer Leadership Vision 2024 Report
Chief Compliance Officer Leadership Vision 2024 ReportChief Compliance Officer Leadership Vision 2024 Report
Chief Compliance Officer Leadership Vision 2024 Report
Compliance Vision
 
Business Lessons From Emmanuel Katto Uganda
Business Lessons From Emmanuel Katto UgandaBusiness Lessons From Emmanuel Katto Uganda
Business Lessons From Emmanuel Katto Uganda
OliviaCox14
 
Mid America Trucking Show Exhibitor List 2024 - Exhibitors Data
Mid America Trucking Show Exhibitor List 2024 - Exhibitors DataMid America Trucking Show Exhibitor List 2024 - Exhibitors Data
Mid America Trucking Show Exhibitor List 2024 - Exhibitors Data
Exhibitors Data
 
Cracking the Corporate Social Responsibilty Code.pptx
Cracking the Corporate Social Responsibilty Code.pptxCracking the Corporate Social Responsibilty Code.pptx
Cracking the Corporate Social Responsibilty Code.pptx
Workforce Group
 
The-Three-Pillars-of-Doctoral-Research-What-Why-and-How (1).pptx
The-Three-Pillars-of-Doctoral-Research-What-Why-and-How (1).pptxThe-Three-Pillars-of-Doctoral-Research-What-Why-and-How (1).pptx
The-Three-Pillars-of-Doctoral-Research-What-Why-and-How (1).pptx
Jindal Global University, Sonipat Haryana 131001
 

Recently uploaded (20)

The Importance of Public Relations for New Graduates.pdf
The Importance of Public Relations for New Graduates.pdfThe Importance of Public Relations for New Graduates.pdf
The Importance of Public Relations for New Graduates.pdf
 
Restaurant Chiraz Sindbad Hotel Hammamet
Restaurant Chiraz Sindbad Hotel HammametRestaurant Chiraz Sindbad Hotel Hammamet
Restaurant Chiraz Sindbad Hotel Hammamet
 
WAM Corporate Presentation July 2024.pdf
WAM Corporate Presentation July 2024.pdfWAM Corporate Presentation July 2024.pdf
WAM Corporate Presentation July 2024.pdf
 
Floating Pontoon | Premier marine solution
Floating Pontoon | Premier marine solutionFloating Pontoon | Premier marine solution
Floating Pontoon | Premier marine solution
 
upGrad_Case_Study_by_Himanshu_Singh.pptx
upGrad_Case_Study_by_Himanshu_Singh.pptxupGrad_Case_Study_by_Himanshu_Singh.pptx
upGrad_Case_Study_by_Himanshu_Singh.pptx
 
What's your strategy? Getting tactical about being strategic.
What's your strategy? Getting tactical about being strategic.What's your strategy? Getting tactical about being strategic.
What's your strategy? Getting tactical about being strategic.
 
Movers near me in Dubai , Best Packers and Movers In Dubai
Movers near me in Dubai , Best Packers and Movers In DubaiMovers near me in Dubai , Best Packers and Movers In Dubai
Movers near me in Dubai , Best Packers and Movers In Dubai
 
Virtual Production Tool Set and Technologies Redefining Cinema.pdf
Virtual Production Tool Set and Technologies Redefining Cinema.pdfVirtual Production Tool Set and Technologies Redefining Cinema.pdf
Virtual Production Tool Set and Technologies Redefining Cinema.pdf
 
Gym business MODEL .pdf .
Gym business MODEL .pdf                 .Gym business MODEL .pdf                 .
Gym business MODEL .pdf .
 
Busty Girls Call Navi Mumbai 🎈🔥9920725232 🔥💋🎈 Provide Best And Top Girl Servi...
Busty Girls Call Navi Mumbai 🎈🔥9920725232 🔥💋🎈 Provide Best And Top Girl Servi...Busty Girls Call Navi Mumbai 🎈🔥9920725232 🔥💋🎈 Provide Best And Top Girl Servi...
Busty Girls Call Navi Mumbai 🎈🔥9920725232 🔥💋🎈 Provide Best And Top Girl Servi...
 
ハワイ大学留学プログラム最終プレゼン「ハワイ大学マノア校におけるシェアリングモビリティの提案」
ハワイ大学留学プログラム最終プレゼン「ハワイ大学マノア校におけるシェアリングモビリティの提案」ハワイ大学留学プログラム最終プレゼン「ハワイ大学マノア校におけるシェアリングモビリティの提案」
ハワイ大学留学プログラム最終プレゼン「ハワイ大学マノア校におけるシェアリングモビリティの提案」
 
Honoring and Understanding the Significance of Guru Purnima
Honoring and Understanding the Significance of Guru PurnimaHonoring and Understanding the Significance of Guru Purnima
Honoring and Understanding the Significance of Guru Purnima
 
FURI88 : GAME SLOT PGSOFT PALING GACOR MUDAH MENANG HANYA DISINI
FURI88 : GAME SLOT PGSOFT PALING GACOR MUDAH MENANG HANYA DISINIFURI88 : GAME SLOT PGSOFT PALING GACOR MUDAH MENANG HANYA DISINI
FURI88 : GAME SLOT PGSOFT PALING GACOR MUDAH MENANG HANYA DISINI
 
High Girls Call Nashik 000XX00000 Provide Best And Top Girl Service And No1 i...
High Girls Call Nashik 000XX00000 Provide Best And Top Girl Service And No1 i...High Girls Call Nashik 000XX00000 Provide Best And Top Girl Service And No1 i...
High Girls Call Nashik 000XX00000 Provide Best And Top Girl Service And No1 i...
 
A Playbook for Solo & Siloed Data Science Practitioners
A Playbook for Solo & Siloed Data Science PractitionersA Playbook for Solo & Siloed Data Science Practitioners
A Playbook for Solo & Siloed Data Science Practitioners
 
Chief Compliance Officer Leadership Vision 2024 Report
Chief Compliance Officer Leadership Vision 2024 ReportChief Compliance Officer Leadership Vision 2024 Report
Chief Compliance Officer Leadership Vision 2024 Report
 
Business Lessons From Emmanuel Katto Uganda
Business Lessons From Emmanuel Katto UgandaBusiness Lessons From Emmanuel Katto Uganda
Business Lessons From Emmanuel Katto Uganda
 
Mid America Trucking Show Exhibitor List 2024 - Exhibitors Data
Mid America Trucking Show Exhibitor List 2024 - Exhibitors DataMid America Trucking Show Exhibitor List 2024 - Exhibitors Data
Mid America Trucking Show Exhibitor List 2024 - Exhibitors Data
 
Cracking the Corporate Social Responsibilty Code.pptx
Cracking the Corporate Social Responsibilty Code.pptxCracking the Corporate Social Responsibilty Code.pptx
Cracking the Corporate Social Responsibilty Code.pptx
 
The-Three-Pillars-of-Doctoral-Research-What-Why-and-How (1).pptx
The-Three-Pillars-of-Doctoral-Research-What-Why-and-How (1).pptxThe-Three-Pillars-of-Doctoral-Research-What-Why-and-How (1).pptx
The-Three-Pillars-of-Doctoral-Research-What-Why-and-How (1).pptx
 

Real-Time Data. Real-World Impact Brochure

  • 2. >175k unique investigators >15k protocols EXCEEDING RECRUITMENT GOALS FOR A GLOBAL MULTI-STUDY REGISTRATION PROGRAM PILOTING A VIRTUAL REAL WORLD EVIDENCE STUDY CLIENT CHALLENGE CLIENT CHALLENGE REAL-WORLD IMPACT REAL-WORLD IMPACT Result: Achieved “first patient in” requirement ahead of schedule for all studies in the program. Beat historical industry performance across a number of key metrics: 18% fewer weeks from final protocol to FPI | 75% more high-performing sites 31% more patients/site/month | 41% fewer non-performing sites Result: Conducted two successful pilot studies recruiting 315 patients across 65 Patient Service Centers. The pharma company is planning to scale up 10x from the pilot to a full national model. Randomize 2,700 patients within a very narrow timeframe for a suite of registration studies Develop a less costly, “site-less” approach to conduct a study collecting survey and laboratory data Study needed to be national in scope while reducing the patient travel burden Leveraged Xcellerate® historical investigator database to identify and secure highest performing investigators in indication Get all sites across the globe up and running as quickly as possible Based on extensive feasibility outreach and site capacity assessment, efficiencies were identified that allowed effective overlapping of sites across the program resulting in accelerated site start-up and reduced clinical costs Developed a cross-enterprise virtual study model leveraging the Covance patient support call center, local LabCorp Patient Service Centers and Covance Central Labs to screen participants, collect lab specimens and analyze lab results, respectively • Online screening, e-consent and enrollment • Call center acting as virtual site coordinators • Fully integrated project oversight and data management LabCorp Patient Service Centers in the pilot 65
  • 3. Million Patients >150 million patients >30 billion test results RESCUED PATIENT ENROLLMENT FOR A STUDY OF A RARE MUTATION PROTOCOL DESIGN TO MAXIMIZE PATIENT ENROLLMENT OPPORTUNITY CLIENT CHALLENGE CLIENT CHALLENGE REAL-WORLD IMPACT REAL-WORLD IMPACT Result: With 274 sites across 28 countries, patient enrollment is on now on track for the initial milestone and has regained its advantage in the recruitment competitive landscape. Result: The eligible patient population increased by +50% without compromising the objectives of the trial. Analyzed LabCorp de-identified clinical laboratory data to discern whether small protocol changes could accelerate recruitment Leveraged LabCorp de-identified clinical laboratory data with health information on patients with the rare mutation Increased recruitment activities in the US leveraging the LabCorp sales force to reach out to physicians to gauge interest as investigators and to recruit AML patients Data helped to identify that making minor changes to the eGFR cutoff would increase the patient pool size therefore reducing recruitment timelines Study to test if a drug reduced progression of kidney disease in patients with Type II diabetes Difficulty identifying available sites as landscape changed rapidly driving increased competition Pharma’s preferred sites were unavailable Study was looking for a small subset of patients which represented <7% of patients Seeking patients with AML and a rare genetic mutation <15% of AML patients >
  • 4. *Average time savings based on an analysis of trials processed through Covance Central Labs with Protocol Finalization date after 1/1/2009 for the specific clinical indications. Past performance is not a guarantee of future results, and a variety of factors other than CRO performance can impact timing of clinical studies. Covance Inc. is the global drug development business of Laboratory Corporation of America Holdings (LabCorp). COVANCE is a registered trademark and marketing name used by Covance Inc. and its subsidiaries around the world. The Americas +1.888.COVANCE (+1.888.268.2623) +1.609.452.4440 or +1.910.338.4760 Europe/Africa +00.800.2682.2682 +44.1423.500888 or +44.1753.512000 Asia Pacific +800.6568.3000 +65.6.5686588 © Copyright 2018 Covance Inc. BROCVD018-0618 REAL-TIME DATA. REAL-WORLD IMPACT. Talk to a representative to find out how Covance can impact your studies. LEARN MORE AT COVANCE.COM/REALIMPACT FOR DATA-DRIVEN RESULTS, IQ IS NOT ENOUGH. Up to 60% of clinical development time and 40% of cost are spent on patient recruitment. Data can help, but simply accessing more data only muddies your decision making. With Covance, you get the right analysis on the right data to empower your studies. Recruit eligible patients that fit your protocol faster, identify and secure proven and/or new sites, forecast and measure progress more efficiently. With Covance’s proprietary data, your program hits its mark. PROTOCOL FINALIZATION TO LAST PATIENT IN Number of Weeks*